215 related articles for article (PubMed ID: 28167768)
21. Lysophospholipids prevent binding of a cytolytic protein ostreolysin to cholesterol-enriched membrane domains.
Chowdhury HH; Rebolj K; Kreft M; Zorec R; Macek P; Sepcić K
Toxicon; 2008 Jun; 51(8):1345-56. PubMed ID: 18455213
[TBL] [Abstract][Full Text] [Related]
22. Perfringolysin O: The Underrated Clostridium perfringens Toxin?
Verherstraeten S; Goossens E; Valgaeren B; Pardon B; Timbermont L; Haesebrouck F; Ducatelle R; Deprez P; Wade KR; Tweten R; Van Immerseel F
Toxins (Basel); 2015 May; 7(5):1702-21. PubMed ID: 26008232
[TBL] [Abstract][Full Text] [Related]
23. Interaction of Cholesterol with Perfringolysin O: What Have We Learned from Functional Analysis?
Savinov SN; Heuck AP
Toxins (Basel); 2017 Nov; 9(12):. PubMed ID: 29168745
[TBL] [Abstract][Full Text] [Related]
24. Macrophages release plasma membrane-derived particles rich in accessible cholesterol.
He C; Hu X; Weston TA; Jung RS; Sandhu J; Huang S; Heizer P; Kim J; Ellison R; Xu J; Kilburn M; Bensinger SJ; Riezman H; Tontonoz P; Fong LG; Jiang H; Young SG
Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8499-E8508. PubMed ID: 30127022
[TBL] [Abstract][Full Text] [Related]
25. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts).
Waheed AA; Shimada Y; Heijnen HF; Nakamura M; Inomata M; Hayashi M; Iwashita S; Slot JW; Ohno-Iwashita Y
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4926-31. PubMed ID: 11309501
[TBL] [Abstract][Full Text] [Related]
26. Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin.
Ramachandran R; Heuck AP; Tweten RK; Johnson AE
Nat Struct Biol; 2002 Nov; 9(11):823-7. PubMed ID: 12368903
[TBL] [Abstract][Full Text] [Related]
27. Use of mutant 125I-perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells.
Das A; Goldstein JL; Anderson DD; Brown MS; Radhakrishnan A
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10580-5. PubMed ID: 23754385
[TBL] [Abstract][Full Text] [Related]
28. Domain 4 (D4) of Perfringolysin O to Visualize Cholesterol in Cellular Membranes-The Update.
Maekawa M
Sensors (Basel); 2017 Mar; 17(3):. PubMed ID: 28273804
[TBL] [Abstract][Full Text] [Related]
29. The influence of natural lipid asymmetry upon the conformation of a membrane-inserted protein (perfringolysin O).
Lin Q; London E
J Biol Chem; 2014 Feb; 289(9):5467-78. PubMed ID: 24398685
[TBL] [Abstract][Full Text] [Related]
30. Phospholipid hydrolysis caused by Clostridium perfringens α-toxin facilitates the targeting of perfringolysin O to membrane bilayers.
Moe PC; Heuck AP
Biochemistry; 2010 Nov; 49(44):9498-507. PubMed ID: 20886855
[TBL] [Abstract][Full Text] [Related]
31. Toward Understanding the Subcellular Distributions of Cholesterol and Sphingolipids Using High-Resolution NanoSIMS Imaging.
Brunet MA; Kraft ML
Acc Chem Res; 2023 Apr; 56(7):752-762. PubMed ID: 36913670
[TBL] [Abstract][Full Text] [Related]
32. Transmembrane protein (perfringolysin o) association with ordered membrane domains (rafts) depends upon the raft-associating properties of protein-bound sterol.
Lin Q; London E
Biophys J; 2013 Dec; 105(12):2733-42. PubMed ID: 24359745
[TBL] [Abstract][Full Text] [Related]
33. Detection of esterified cholesterol in murine Bruch's membrane wholemounts with a perfringolysin O-based cholesterol marker.
Rudolf M; Mohi A; Dettbarn MC; Miura Y; Aherrahrou Z; Ranjbar M; Mutus B; Knobloch JK
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4759-67. PubMed ID: 24985479
[TBL] [Abstract][Full Text] [Related]
34. A basic model for the association of ligands with membrane cholesterol: application to cytolysin binding.
Lange Y; Tabei SMA; Steck TL
J Lipid Res; 2023 Apr; 64(4):100344. PubMed ID: 36791915
[TBL] [Abstract][Full Text] [Related]
35. Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an alpha-helical to beta-sheet transition identified by fluorescence spectroscopy.
Shepard LA; Heuck AP; Hamman BD; Rossjohn J; Parker MW; Ryan KR; Johnson AE; Tweten RK
Biochemistry; 1998 Oct; 37(41):14563-74. PubMed ID: 9772185
[TBL] [Abstract][Full Text] [Related]
36. Quantitative Measurement of Cholesterol in Cell Populations Using Flow Cytometry and Fluorescent Perfringolysin O.
Li J; Lee PL; Pfeffer SR
Methods Mol Biol; 2017; 1583():85-95. PubMed ID: 28205169
[TBL] [Abstract][Full Text] [Related]
37. Sphingomyelinase activates GLUT4 translocation via a cholesterol-dependent mechanism.
Liu P; Leffler BJ; Weeks LK; Chen G; Bouchard CM; Strawbridge AB; Elmendorf JS
Am J Physiol Cell Physiol; 2004 Feb; 286(2):C317-29. PubMed ID: 14522816
[TBL] [Abstract][Full Text] [Related]
38. Perfringolysin O association with ordered lipid domains: implications for transmembrane protein raft affinity.
Nelson LD; Chiantia S; London E
Biophys J; 2010 Nov; 99(10):3255-63. PubMed ID: 21081073
[TBL] [Abstract][Full Text] [Related]
39. Effects of sphingomyelin and phosphatidylcholine degradation on cyclodextrin-mediated cholesterol efflux in cultured fibroblasts.
Ohvo H; Olsio C; Slotte JP
Biochim Biophys Acta; 1997 Nov; 1349(2):131-41. PubMed ID: 9421186
[TBL] [Abstract][Full Text] [Related]
40. Rapid turn-over of plasma membrane sphingomyelin and cholesterol in baby hamster kidney cells after exposure to sphingomyelinase.
Slotte JP; Härmälä AS; Jansson C; Pörn MI
Biochim Biophys Acta; 1990 Dec; 1030(2):251-7. PubMed ID: 2261487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
